[1]
M. T. Gabr, N. S. El-Gohary, E. R. El-Bendary, and M. M. El-Kerdawy, “EGFR tyrosine kinase targeted compounds: in vitro antitumor activity and molecular modeling studies of new benzothiazole and pyrimido[2,1-b]benzothiazole derivatives”, EXCLI J., vol. 13, pp. 573–585, May 2014.